Hirofumi Matsuoka Selected Research

ethyl loflazepate

1/2020

Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirofumi Matsuoka Research Topics

Disease

15	Asthma (Bronchial Asthma) 04/2017 - 03/2006
8	Neoplasms (Cancer) 04/2022 - 10/2012
5	Cough 03/2012 - 04/2007
4	Cough-Variant Asthma 01/2012 - 03/2006
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 09/2017
3	Carcinogenesis 01/2020 - 07/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 04/2017 - 01/2012
3	Inflammation (Inflammations) 01/2012 - 03/2008
3	Chronic Cough 01/2011 - 03/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 02/2019
2	Endometrial Neoplasms (Endometrial Cancer) 04/2022 - 04/2021
2	Urinary Tract Infections (Urinary Tract Infection) 06/2020 - 12/2019
2	Pain (Aches) 01/2020 - 01/2012
2	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2012
2	Mouth Neoplasms (Oral Cancer) 01/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 10/2012
2	Respiratory Hypersensitivity 01/2012 - 01/2011
2	Respiratory Sounds (Crackle) 03/2009 - 03/2006
1	Rhabdomyolysis 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 04/2022
1	Body Weight (Weight, Body) 01/2022
1	Cryptorchidism (Undescended Testes) 10/2021
1	Atrophy 10/2021
1	Acute Promyelocytic Leukemia 04/2021
1	Radicular Cyst 01/2021
1	Oral Lichen Planus 01/2021
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 06/2020
1	Constipation 06/2020
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Burning Mouth Syndrome (Syndrome, Burning Mouth) 01/2020
1	Hypertension (High Blood Pressure) 12/2019
1	Proteinuria 12/2019
1	Sarcopenia 02/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Pulmonary Alveolar Proteinosis 05/2015
1	Hypoxia (Hypoxemia) 05/2015

Drug/Important Bio-Agent (IBA)

6	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2016 - 03/2006
5	Methacholine Chloride (Methacholine)FDA Link 03/2012 - 11/2006
3	Immunoglobulin E (IgE)IBA 04/2017 - 04/2009
3	AllergensIBA 11/2014 - 04/2009
3	Capsaicin (Zostrix)FDA Link 01/2012 - 04/2007
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2011
2	ProstaglandinsIBA 01/2017 - 01/2012
2	AntibodiesIBA 05/2015 - 11/2014
2	SteroidsIBA 01/2013 - 03/2009
2	ErbB Receptors (EGF Receptor)IBA 10/2012 - 10/2012
2	Gefitinib (Iressa)FDA Link 10/2012 - 10/2012
2	Tyrosine Kinase InhibitorsIBA 10/2012 - 10/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2012 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 07/2006
2	Bronchodilator Agents (Bronchodilators)IBA 01/2012 - 03/2009
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022
1	fibrin fragment D (D-dimer)IBA 04/2022
1	immune RNA (I-RNA)IBA 01/2022
1	CorticosteroneIBA 01/2022
1	Inosine FDA Link 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Arsenic Trioxide (Trisenox)FDA Link 04/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Milnacipran (Ixel)FDA Link 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2020
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Sirtuin 1IBA 01/2020
1	ethyl loflazepateIBA 01/2020
1	ParaffinIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	bicalutamide (Casodex)FDA LinkGeneric 01/2020
1	Succimer (Dimercaptosuccinic Acid)FDA Link 12/2019
1	EndotoxinsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	CarcinogensIBA 01/2019
1	DNA Methyltransferase 3AIBA 09/2017
1	Arecoline (Arecolin)IBA 07/2017
1	Matrix Metalloproteinases (MMPs)IBA 07/2017
1	Tissue Inhibitor of Metalloproteinase-2IBA 07/2017
1	Messenger RNA (mRNA)IBA 07/2017
1	Tissue Inhibitor of MetalloproteinasesIBA 07/2017
1	Rheumatoid FactorIBA 04/2017
1	AutoantibodiesIBA 04/2017
1	Antinuclear AntibodiesIBA 04/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Oxygen (Dioxygen)IBA 01/2016
1	Ambroxol (Mucosolvan)IBA 05/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2015

Therapy/Procedure

8	Therapeutics 04/2021 - 11/2007
5	Drug Therapy (Chemotherapy) 04/2021 - 10/2012
1	Prostatectomy (Retropubic Prostatectomy) 10/2022
1	Robotic Surgical Procedures 10/2022
1	Orchiopexy 10/2021
1	Orchiectomy (Orchidectomy) 10/2021
1	Antibiotic Prophylaxis 06/2020
1	Craniotomy 01/2020
1	Combined Modality Therapy 01/2020
1	Chemoradiotherapy 02/2019
1	Radiotherapy 02/2019
1	Chemoprevention 01/2019